Evidence map›Paper›PMID 38543176›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Target Development towards First Production of High-Molar- Activity

Edgars Mamis, Charlotte Duchemin, Valentina Berlin, Cyril Bernerd, Mathieu Bovigny, Eric Chevallay, Bernard Crepieux, Vadim Maratovich Gadelshin, Reinhard Heinke, Ronaldo Mendez Hernandez and 12 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 5 countries.

Edgars MamisEuropean Organization for Nuclear Research (CERN), Esplanade des Particules 1, 1211 Geneva, Switzerland.ORCID 0000-0003-4276-5469
Charlotte DucheminEuropean Organization for Nuclear Research (CERN), Esplanade des Particules 1, 1211 Geneva, Switzerland.ORCID 0000-0002-3661-7833
Valentina BerlinEuropean Organization for Nuclear Research (CERN), Esplanade des Particules 1, 1211 Geneva, Switzerland.ORCID 0009-0003-3147-5439
Cyril BernerdEuropean Organization for Nuclear Research (CERN), Esplanade des Particules 1, 1211 Geneva, Switzerland.ORCID 0000-0002-2183-9695
Mathieu BovignyEuropean Organization for Nuclear Research (CERN), Esplanade des Particules 1, 1211 Geneva, Switzerland.
Eric ChevallayEuropean Organization for Nuclear Research (CERN), Esplanade des Particules 1, 1211 Geneva, Switzerland.
Bernard CrepieuxEuropean Organization for Nuclear Research (CERN), Esplanade des Particules 1, 1211 Geneva, Switzerland.
Vadim Maratovich GadelshinInstitut für Physik, Johannes Gutenberg Universität, Staudingerweg 7, 55128 Mainz, Germany.
Reinhard HeinkeEuropean Organization for Nuclear Research (CERN), Esplanade des Particules 1, 1211 Geneva, Switzerland.ORCID 0000-0001-6053-1346
Ronaldo Mendez HernandezEuropean Organization for Nuclear Research (CERN), Esplanade des Particules 1, 1211 Geneva, Switzerland.ORCID 0000-0002-2350-5525
Jake David JohnsonEuropean Organization for Nuclear Research (CERN), Esplanade des Particules 1, 1211 Geneva, Switzerland.ORCID 0000-0003-4397-5732
Patrīcija KalniņaEuropean Organization for Nuclear Research (CERN), Esplanade des Particules 1, 1211 Geneva, Switzerland.ORCID 0009-0001-4506-4388
Alexandros KoliatosEuropean Organization for Nuclear Research (CERN), Esplanade des Particules 1, 1211 Geneva, Switzerland.
Laura LambertEuropean Organization for Nuclear Research (CERN), Esplanade des Particules 1, 1211 Geneva, Switzerland.ORCID 0000-0001-8494-0590
Ralf Erik RosselEuropean Organization for Nuclear Research (CERN), Esplanade des Particules 1, 1211 Geneva, Switzerland.
Sebastian RotheEuropean Organization for Nuclear Research (CERN), Esplanade des Particules 1, 1211 Geneva, Switzerland.
Julien ThiboudEuropean Organization for Nuclear Research (CERN), Esplanade des Particules 1, 1211 Geneva, Switzerland.
Felix WeberInstitut für Physik, Johannes Gutenberg Universität, Staudingerweg 7, 55128 Mainz, Germany.ORCID 0000-0001-7702-5706
Klaus WendtInstitut für Physik, Johannes Gutenberg Universität, Staudingerweg 7, 55128 Mainz, Germany.
Rudolfs Jānis ZabolockisInstitute of Chemical Physics (ICP), University of Latvia, Jelgavas Street 1, LV-1004 Riga, Latvia.ORCID 0000-0002-6654-9982
Elīna PajusteInstitute of Chemical Physics (ICP), University of Latvia, Jelgavas Street 1, LV-1004 Riga, Latvia.ORCID 0000-0003-1036-4679
Thierry StoraEuropean Organization for Nuclear Research (CERN), Esplanade des Particules 1, 1211 Geneva, Switzerland.ORCID 0000-0002-4308-1002
European Organization for Nuclear Research · CHJohannes Gutenberg University Mainz · DEUniversity of Latvia · LVHigher Institute of Technologies and Applied Sciences · CU

Funding

Latvian Council of Science lzp-2021/1-0539the European Union's Horizon 2020 research and innovation programme 101008571
6 · The paper itself

Abstract

The radionuclides

Indexed as

ISOL target unitslaser resonant ionizationmass separationmolecular beamsscandium radionuclidestarget materials

Identifiers

PMID38543176
PMCPMC10974744
OpenAlexW4392915542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.